Question 1

What is ANDEXANET ALFA used for?

Accepted Answer

ANDEXANET ALFA (brand name ANDEXXA) is a Other indicated for 1 INDICATIONS AND USAGE ANDEXXA is indicated for patients treated with rivaroxaban or apixaban, inactivated-zhzo) is a recombinant modified human factor Xa (FXa) protein indicated for patients treated with rivaroxaban or apixaban, 14 ) Limitations of Use ANDEXXA has not been shown to be effective for.

Question 2

How does ANDEXANET ALFA work?

Accepted Answer

ANDEXANET ALFA works through the following mechanism: 12.1 Mechanism of Action Coagulation factor Xa (recombinant), inactivated-zhzo exerts its procoagulant effect by binding and sequestering the FXa inhibitors, rivaroxaban and apixaban. Another observed procoagulant effect of the ANDEXXA protein is its ability to bind to, and inhibit the activity of, Tissue Factor Pathway Inhibitor (TFPI). Inhibition of TFPI activity can increase tissue factor (TF)-initiated thrombin generation..

Question 3

What are the most common side effects of ANDEXANET ALFA?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for ANDEXANET ALFA. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is ANDEXANET ALFA the same as ANDEXXA?

Accepted Answer

ANDEXXA is a brand name for ANDEXANET ALFA. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

ANDEXANET ALFA

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations